MRI for Ductal Carcinoma

N/A

Waitlist Available

Led By Kimberly Van Zee, MD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Clinical stage is consistent with Stage 0 or Stage I T1mic at presentation

Be between 18 and 65 years old

Must not have

Be younger than 18 years old

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Upconclusion of the study

Awards & highlights

No Placebo-Only Group

Study Summary

This trial is studying the use of breast MRI in addition to mammography in women who have already been diagnosed with breast cancer to see if it can help find other areas of cancer.

Eligible Conditions

Ductal Carcinoma in Situ
Breast Cancer

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Select...

You have an early stage of cancer, either Stage 0 or Stage I T1mic.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ conclusion of the study

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~conclusion of the study

This trial's timeline: 3 weeks for screening, Varies for treatment, and conclusion of the study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To prospectively evaluate the value of preoperative breast MRI in women with core biopsy-proven DCIS.

Secondary outcome measures

To determine the proportion of all patients in this study in whom breast MRI identifies at least one site of cancer separate from the index lesion.

To estimate re-excision rates and mastectomy rates in patients with DCIS undergoing preoperative MRI.

To estimate the long-term ipsilateral breast recurrence rate in women with DCIS undergoing preoperative breast MRI.

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: 1Experimental Treatment1 Intervention

Women with core biopsy proven DCIS with or without microinvasion seen for surgical consultation at Memorial Sloan-Kettering Cancer Center and for whom operative intervention is planned.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

MRI

2009

Completed Phase 2

~1370

0 / 1Eligibility criteria met

Find a site

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,892 Previous Clinical Trials

587,023 Total Patients Enrolled

Kimberly Van Zee, MDPrincipal Investigator

Memorial Sloan Kettering Cancer Center

2 Previous Clinical Trials

1,460 Total Patients Enrolled

Media Library

MRI Clinical Trial Eligibility Overview. Trial Name: NCT00605982 — N/A

Ductal Carcinoma Research Study Groups: 1

Ductal Carcinoma Clinical Trial 2023: MRI Highlights & Side Effects. Trial Name: NCT00605982 — N/A

MRI 2023 Treatment Timeline for Medical Study. Trial Name: NCT00605982 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are octogenarians eligible to participate in this experimental research?

"The trial is available to patients aged between 21 and 59. There are 1439 clinical trials for individuals over the age of 65, as well as 55 studies that accept participants below 18 years old."

Answered by AI

Could I be a participant in this clinical experiment?

"For this study, 115 individuals aged 21 to 59 with a diagnosis of breast cancer must meet the following qualifications: under 60 years old at time of agreement signature; Stage 0 or I T1mic upon evaluation; core biopsy results demonstrate DCIS and/or microinvasion (no more than .01 cm); planned surgical intervention completed at MSKCC prior to enrollment; informed consent obtained from participant; female."

Answered by AI

Are there any available slots for participants in this research endeavor?

"Per the clinicaltrials.gov listing, this particular research study is not currently open to participants. Initially posted on 10/10/2006 and last updated 11/7/2022, recruitment has temporarily ceased; however, there are still 1,513 other trials welcoming applicants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Breast MRI as a Preoperative Tool for DCIS

2006. "Breast MRI as a Preoperative Tool for DCIS". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00605982.

All > Dcis